APIDRA (Insulin Glulisine) Administered Premeal vs Postmeal in Adult Subjects With Type 2 Diabetes Mellitus Receiving LANTUS (Insulin Glargine) as Basal Insulin: a Multicenter, Randomized, Parallel, Open Label Clinical Study
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2011
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 01 Dec 2011 Results published in the Diabetes, Obesity and Metabolism.
- 06 Oct 2006 Status change
- 06 Nov 2005 New trial record.